stem cells
This Swedish startup wants to reduce the cost, and controversy, around stem cell production
With the news that “mini organs” have been grown for the first time using human stem cells, this futuristic area of bio-medicine is clearly accelerating by leaps and bounds. However,…
Cellino Bio’s founder Nabiha Saklayen didn’t initially intend to enter TechCrunch Disrupt 2021’s Startup Battlefield — it was her PR advisor who threw the startup’s name in the ring as…
Cell-cultured meat is a hot topic, yet the process for producing meat in this manner remains slow and costly.
Quris combines AI with ‘patient on a chip’ to speed drug development and reduce animal testing
The necessity of animal testing is a sad one for the process of drug discovery, but there’s seemingly no good alternative to mice, even though they’re not particularly accurate human…
Cellino is using AI and machine learning to scale production of stem cell therapies
Cellino, a company developing a platform to automate stem cell production, presented today at TechCrunch Disrupt 2021’s Startup Battlefield to detail how its system, which combines AI technology, machine learning,…
Mission Bio raises $70 million to help scale its tech for improving the development of targeted cancer therapies
California-based startup Mission Bio has raised a new $70 million Series C funding round, led by Novo Growth and including participation from Soleus Capital and existing investors Mayfield, Cota and…
Bit Bio’s ‘enter button for the keyboard to the software of life’ nabs the company $41.5 million
Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million…
Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19
Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and Drug Administration to begin early-stage clinical trials on a potential…
Aspen Neuroscience raises $70M for its experimental Parkinson’s Disease treatment
Since 2012, Dr. Jeanne Loring, the founder of the eponymous Loring Lab at Scripps Research, has been thinking about how to use pluripotent stem cells as a potential treatment for…
Newly launched pet health startup Gallant wants you to bank your dog’s stem cells for $990
With $11 million in funding and a mission to open up the doors of regenerative therapies to dogs across the nation, the Los Angeles-based startup Gallant is now opening its…
